No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Express News | Genprex Shares Are Trading Higher After the Company Provided 2024 Updates
Express News | Genprex Issues Letter And Provides 2024 Update; Reached Multiple Clinical Development Milestones In 2024; Patient Treatment Continues In Three Lung Cancer Clinical Trials
Genprex Issues Stockholder Letter and Provides 2024 Corporate Update
12 Health Care Stocks Moving In Friday's Intraday Session
Genprex to Present at the 2024 BIO International Convention
Genprex | 10-Q: Quarterly report